Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy
- PMID: 11525880
- DOI: 10.1016/s0960-8966(01)00201-2
Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy
Abstract
In 1950, Tyler and Stephens reported a remarkable kindred affected with facioscapulohumeral dystrophy (FSHD), consisting of 1249 descendants of a man who emigrated to Utah in 1840. Members of this kindred are still seen in our clinic and, to our knowledge, no member had been tested for deletions at the FSHD1A locus on chromosome 4q35, the common chromosomal rearrangement associated with FSHD. We have identified 971 additional members of this kindred who either were not included in or unborn at the time of the report by Tyler and Stephens, and have identified 120 living members as affected by history or by examination. Members of this kindred contribute to a disease prevalence of nearly 1:15 000 in the Utah/southern Idaho region. We have demonstrated that affected members carry a disease-associated 20 kb deletion allele at the FSHD1A locus. This allele is the same size in multiple, distantly-related branches of the kindred, confirming the meiotic stability of the FSHD1A deletion. This large, genetically homogeneous population of patients represents a unique resource with which to study current questions about FSHD, including the possibilities of anticipation and parental transmission effects.
Similar articles
-
An inherited 4q35-EcoRI-DNA-fragment of 35 kb in a family with a sporadic case of facioscapulohumeral muscular dystrophy (FSHD).Neuromuscul Disord. 2000 Mar;10(3):178-81. doi: 10.1016/s0960-8966(99)00102-9. Neuromuscul Disord. 2000. PMID: 10734264
-
Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.Arch Neurol. 2003 Oct;60(10):1421-5. doi: 10.1001/archneur.60.10.1421. Arch Neurol. 2003. PMID: 14568813 Clinical Trial.
-
[Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Oct;25(5):581-4. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003. PMID: 14650163 Chinese.
-
[Facioscapulohumeral muscular dystrophy (FSHD)].Nihon Rinsho. 1997 Dec;55(12):3181-5. Nihon Rinsho. 1997. PMID: 9436432 Review. Japanese.
-
Molecular diagnosis of facioscapulohumeral muscular dystrophy.Expert Rev Mol Diagn. 2002 Mar;2(2):160-71. doi: 10.1586/14737159.2.2.160. Expert Rev Mol Diagn. 2002. PMID: 11962336 Review.
Cited by
-
Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy.Neuromuscul Disord. 2013 Apr;23(4):306-12. doi: 10.1016/j.nmd.2013.01.008. Epub 2013 Feb 11. Neuromuscul Disord. 2013. PMID: 23406877 Free PMC article.
-
FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).PLoS One. 2015 Feb 19;10(2):e0117665. doi: 10.1371/journal.pone.0117665. eCollection 2015. PLoS One. 2015. PMID: 25695429 Free PMC article.
-
CRISPR mediated targeting of DUX4 distal regulatory element represses DUX4 target genes dysregulated in Facioscapulohumeral muscular dystrophy.Sci Rep. 2021 Jun 15;11(1):12598. doi: 10.1038/s41598-021-92096-0. Sci Rep. 2021. PMID: 34131248 Free PMC article.
-
Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy.J Neuromuscul Dis. 2014;1(2):181-190. doi: 10.3233/JND-140034. J Neuromuscul Dis. 2014. PMID: 25705588 Free PMC article.
-
Dominantly inherited muscle disorders: understanding their complexity and exploring therapeutic approaches.Dis Model Mech. 2024 Oct 1;17(10):dmm050720. doi: 10.1242/dmm.050720. Epub 2024 Nov 6. Dis Model Mech. 2024. PMID: 39501809 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources